Tomoyuki Katsuno
-
- Diabetes Management and Research 22
- Diabetes Treatment and Management 21
- Diabetes, Cardiovascular Risks, and Lipoproteins 3
- Diet, Metabolism, and Disease 2
- Nephrology top 10%
-
- Pancreatic function and diabetes 10
-
- Pharmacology and Obesity Treatment 2
-
- Metabolism, Diabetes, and Cancer 12
-
- Diabetes and associated disorders 3
Tomoyuki Katsuno
39 papers receiving 538 citations
Peers
Comparison fields: 5 of 73
- Endocrinology, Diabetes and Metabolism 355
- Nephrology 71
- Surgery 136
- Physiology 69
- Pharmacology 41
Countries citing papers authored by Tomoyuki Katsuno
This map shows the geographic impact of Tomoyuki Katsuno's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomoyuki Katsuno with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomoyuki Katsuno more than expected).
Fields of papers citing papers by Tomoyuki Katsuno
This network shows the impact of papers produced by Tomoyuki Katsuno. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomoyuki Katsuno. The network helps show where Tomoyuki Katsuno may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Tomoyuki Katsuno, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 4 | |
| 2 | 2023 | 0 | |
| 3 | 2023 | 7 | |
| 4 | 2023 | 2 | |
| 5 | 2023 | 2 | |
| 6 | 2021 | 3 | |
| 7 | 2017 | 53 | |
| 8 | 2016 | 2 | |
| 9 | 2014 | 14 | |
| 10 | 2014 | 7 | |
| 11 | Effects of combination therapy with mitiglinide and voglibose on postprandial plasma glucose in patients with type 2 diabetes mellitus | 2013 | 2 |
| 12 | 2013 | 13 | |
| 13 | 2013 | 38 | |
| 14 | 2012 | 18 | |
| 15 | 2011 | 10 | |
| 16 | 2011 | 6 | |
| 17 | Asymmetric dimetylarginine (ADMA) could affect on cardiovascular complications in type 2 diabetes, particularly complicated with nephropathy | 2010 | 1 |
| 18 | 2010 | 17 | |
| 19 | 2006 | 27 | |
| 20 | 2000 | 7 |
About Tomoyuki Katsuno
Tomoyuki Katsuno is a scholar working on Endocrinology, Diabetes and Metabolism, Nephrology and Transplantation, having authored 40 papers that have together received 554 indexed citations. Recurring topics across this work include Diabetes Management and Research (22 papers), Diabetes Treatment and Management (21 papers), Metabolism, Diabetes, and Cancer (12 papers), Pancreatic function and diabetes (10 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (3 papers), Diabetes and associated disorders (3 papers), Pharmacology and Obesity Treatment (2 papers) and Diet, Metabolism, and Disease (2 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (355 citations), Nephrology (71 citations) and Surgery (136 citations). Tomoyuki Katsuno has collaborated with scholars based in Japan, Australia and France. Frequent co-authors include Mitsuyoshi Namba, Jun‐ichiro Miyagawa, Yoshiki Kusunoki, Masayuki Miuchi, Toshihiro Matsuo, Tomoya Hamaguchi, Fumihiro Ochi, Hidenori Koyama, Takafumi Akagami and Hiroki Ikeda.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.